Inotropic and electrophysiological effects of BDF 9148, a congener of DPI 201–106, in guinea‐pig atria and papillary muscles
Open Access
- 1 August 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 103 (4), 1939-1945
- https://doi.org/10.1111/j.1476-5381.1991.tb12356.x
Abstract
1 BDF 9148 is a newly synthesized congener of DPI 201–106 in which the piperazidinyl moiety has been replaced by an azetidine-3-oxy-moiety. The inotropic effect of both drugs was studied as well as their influence on the action potential, by use of standard microelectrode techniques. 2 BDF 9148 increased the contractile force of guinea-pig atria and papillary muscles. The EC50 was 1.32 × 10−7mol l−1 and 0.7 × 10−6 mol l−1 respectively. DPI 201–106 was effective in a similar concentration-range, the EC50 being 2.6 × 10−7mol l−1 for atria and 2.8 × 10−7 mol l−1 for papillary muscles. 3 Both drugs caused a concentration-dependent prolongation of the relaxation time of the isometric contraction curve. With 10−6 mol l−1 BDF 9148, the mean increase was 39.1 ± 4.4 ms in atria and 39.4 ± 7.5 ms in papillary muscles while 10−6 mol l−1 DPI 201–106 caused increases of 56.7 ± 2.5 ms and 79.3 ± 11.7 ms, respectively. The effect of BDF 9148 was not prevented by propranolol, but was reversed by 3 × 10−6 mol l−1 tetrodotoxin. Pretreatment of atria with 3 × 10−8 mol l−1 BDF shifted the concentration-response curve of ouabain to the left and reduced the EC50 of the glycoside from 3.21 × 10−7 mol l−1 to 2 × 10−7 mol l−1. 4 BDF 9148 and DPI 201–106 concentration-dependently increased the action potential duration of papillary muscles and their functional refractory period. The drugs did not modify the resting potential, the action potential amplitude or the maximum depolarization velocity. 5 All effects of BDF 9148 persisted after washout. The lipophilic drug accumulated in the tissues and the tissue drug concentration was little reduced by washout of BDF 9148 from the organ bath. 6 In contrast to DPI 201–106, which had a prominent negative chronotropic effect in right atria, BDF 9148 caused only a slight reduction of the beating frequency with the largest (3 × 10−5 mol l−1) concentration. 7 The results are consistent with BDF 9148 being a sodium channel activator with much weaker influence on the beating frequency than the parent compound DPI 201–106.Keywords
This publication has 21 references indexed in Scilit:
- Influence of BDF 9148 on contractile force and action potentials of isolated guinea-pig atria and papillary musclesEuropean Journal of Pharmacology, 1990
- Interaction of DPI 201–106 with Cardiac GlycosidesJournal of Cardiovascular Pharmacology, 1989
- Subsensitivity of the Failing Human Heart to Isoprenaline and Milrinoneo is Related to β-Adrenoceptor DownregulationJournal of Cardiovascular Pharmacology, 1988
- DPI 201-106 for severe congestive heart failureThe American Journal of Cardiology, 1987
- The effect of a new inotropic agent, DPI 201‐106, on systolic time intervals and the electrocardiogram in healthy subjects.British Journal of Clinical Pharmacology, 1987
- Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.Circulation, 1987
- The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparationsEuropean Journal of Pharmacology, 1985
- Mechanism of the Vasodilator Effects of the Cardiotonic Agent DPI 201-106Journal of Cardiovascular Pharmacology, 1985
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Cardioactive substances that prolong the open state of sodium channelsReviews of physiology, biochemistry and pharmacology, 1982